NCT03886688View on ClinicalTrials.gov

HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

May 14, 2019

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Healthy
Interventions
DRUG

HEC53856

oral administration

DRUG

placebo

oral administration

Trial Locations (1)

130000

First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY

NCT03886688 - HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers | Biotech Hunter | Biotech Hunter